Daily news email for August 14, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
ZZ Biotech Initiates Phase 1 Study with 3K3A-APC for the Treatment of Acute Ischemic Stroke

AiCuris Promising Drugs Against Herpes Simplex (AIC316) and Human Cytomegalovirus (Letermovir, ...

CEVEC Licenses its Proprietary Human Cell Lines to Paragon Bioservices, Inc.

Cambridge Research Biochemicals Signs Deal with LI-COR Biosciences for Infrared Dye Labelled ...

2. Laupheimer Zelltage Attracts Top Scientists to Discuss Recent Advances in Biomanufacturing

BioSpace
Protein That Helps Tumor Blood Vessels Mature Could Make Cancer Drugs More Effective, Sanford-Burnham Medical Research Institute Study

National Health Service Chief Warns Over National Institute for Clinical Excellence (NICE) Drug Blacklists

Gene Discovery Could Improve Treatment for Acute Myeloid Leukemia, Study

Kineta Inc. Pulls in $5.8 Million for Autoimmune Drug

Fat-Free Immortal Chocolate Created by University of Warwick

BioSpace - Breaking News
Burnet Institute Release: Major Breakthrough in Hepatitis C Vaccine Development

Cortex Pharmaceuticals, Inc. and Consummate Merger

TONIX Pharmaceuticals, Inc. Reports That Sublingual Formulation of Fibromyalgia Drug Reduces Production of a Psychoactive Metabolite, Improving Suitability for Long-Term, Chronic Treatment

Soricimed Biopharma, Inc. Announces First Patient Treated in Phase I Clinical Trial of New Cancer Drug, SOR-C13

Proteonomix, Inc. (PROT) Receives FDA Permission to Initiate Company-Sponsored Phase 1 Clinical Trial With UMK-121 in Patients with End-Stage Liver Disease

Biotech News - Business Wire
Altura Medical Announces G. Ray Martin Named President & CEO

FertilityAuthority Launches Online Scheduling for Fertility Clinic and Fertility Doctor Appointments

BioHorizons Launches MinerOss® Cancellous Providing Dental Implant Professionals a Wide Variety of Bone Grafting Solutions

Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Disposable Anesthesia Products

Critical Diagnostics Expands Management Team with Regulatory Affairs Veteran

Biotech News - PR Newswire
Morphotek®, Inc. Opens 60,000-square-foot Manufacturing Plant

Wockhardt to launch generic version of BPH drug Uroxatral®

MultiCell Announces Results of Shareholders' Meeting

Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments

Use Notebook Studies to Ensure Successful Reusable Device Cleaning Validations, Recommends Microtest Laboratories

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
Innovation Bank Proposed

China Invests in U.K. Diagnostics Startup

Alzheimer's Drug Bapineuzumab Fails in Second Trial

Nanobiotix teams up with PharmaEngine in Nanomedicine Deal

Pharma Heads Back to School

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
Radiology Quality Institute eBook Defines Quality Standards in Radiology

Research and Markets: Sleep Disorders Global Clinical Trials Review, H1, 2012

Research and Markets: Fabry Disease Global Clinical Trials Review, H1, 2012

Research and Markets: Bradycardia Global Clinical Trials Review, H1, 2012

Research and Markets: Adenovirus Infections Global Clinical Trials Review, H1, 2012

Clinical Trials - PR Newswire
Sound Interventions Updates Results From "SOUND-ITV" Trial Of Ultrasound-based Renal Denervation For Resistant Hypertension

Fetal Surveillance Company, PeriGen, Inc., to Collaborate with National Institute of Child Health and Human Development to Research Fetal Heart Rate Patterns During Labor

First Patient Procedure Using the ClearPoint® Neuro Intervention System Performed at Memorial Sloan Kettering Cancer Center in Pediatric Brain Cancer Clinical Trial

Over-the-Counter Prostate Treatment PHC® Awarded U.S. Patent

Muscular Dystrophy Association And The ALS Association Fund Clinical Trial Of Diaphragm Pacing System In People With ALS

CNN Top Stories
New words added to dictionary

41 killed in Afghanistan attacks

Ron Palillo, TV's 'Horshack,' dead at 63

Steve Jobs' home burglarized

Ryan in college

Contract Pharma
Quintiles Acquires Expression Analysis

Laureate, ZZ Biotech Complete Protein Production Pact

InSite Vision, Merck Amend AzaSite Terms

Elan To Spin-Off Discovery Unit

Molecular Profiles, Onyx Form Services Alliance

FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Riesgo de convulsiones en pacientes con esclerosis múltiple que toman Ampyra (dalfampridine)

Comunicado de la FDA sobre la seguridad de los medicamentos: Riesgo de convulsiones en pacientes con esclerosis múltiple que toman Ampyra (dalfampridine)

FDA Drug Safety Communication: Seizure risk for multiple sclerosis patients who take Ampyra (dalfampridine)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva información sobre la prolongación del intervalo QT con ondansetrón (Zofran)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva información sobre la prolongación del intervalo QT con ondansetrón (Zofran)

FDA News - Business Wire
Proteonomix Receives FDA Permission to Initiate Company-Sponsored Phase 1 Clinical Trial with UMK-121 in Patients with End-Stage Liver Disease

Digital Marketing Teams Solidify Their Staffing at Top 10 Pharma Companies

Samenvatting: Sapheon maakt jaarlijkse follow-up data bekend van spataderonderzoek bij 38 patiënten

Biovest Conducts End of Phase III Review with FDA of BiovaxID as Consolidation Therapy in Non-Hodgkin's Lymphoma

Santarus Announces FDA Extension of UCERIS New Drug Application Target Action Date to January 16, 2013

FDA Press Releases
FDA approves vaccines for the 2012-2013 influenza season

FDA approves vaccine formulation for the 2012-2013 influenza season

FDA approves Lucentis to treat diabetic macular edema

FDA approves Marqibo to treat rare type of leukemia

FDA revises safety information and limits use of Stryker Wingspan brain stent system

FDA Vaccines, Blood and Biologics - What's New
Black Widow Spider Antivenin (Latrodectus mactans)(Equine) Packaged Lot 0585Z: Information about Expiration Date and Use

Cord Blood Banking - Information for Consumers

Package Insert - Twinrix

Direct Recall Classification Program

Draft Guidance for Industry: Amendment to Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products

FierceBiotech
Celgene, Norwegian biotech team on HIV immunotherapy with Revlimid

UPDATED: Genentech whistleblower suit claims execs dangerously rushed Pi3K study

Booming Shire closes in on new campus site for U.S. HQ

Icahn slams Forest for undisclosed FDA warning

Onconova hauls in $50M to fuel late-stage leukemia program

FierceBiotech IT
Quintiles gains genomic, bioinformatics know-how in buyout

U.K. scientists tap into ehealth research with Centers of Excellence

Merck to draw on social network for psoriasis patients

Schadt reflects on first year at $100M genomics center

FDA taps data-mining tech for drug safety research

FierceBiotech Research
Prosthetic retina restores partial sight to blind mice

Gene offers tantalizing leukemia target

Newly discovered, overexpressed gene offers tantalizing leukemia target

University of Cambridge debuts latest stem cell research institute

Nanomaterial propels self-repair for damaged hearts

FiercePharma
Docs see twice as many iPad-carrying reps

What are Avastin's chances in its next NICE review

FTC: Cash isn't required to qualify as pay-for-delay

Whistleblower: Genentech put trial subjects at risk in rushed study

Pfizer, AstraZeneca strike $250M-plus deal for OTC Nexium

FiercePharma Manufacturing
FDA turns to Merck on Sanofi cancer drug shortage

GPhA drug shortage plan passes FTC smell test

Internet drug dealer gets 10 years but feds want his Chinese boss

Acino opens German plant to make Bayer birth control patches

FDA asks Merck to make up for Sanofi cancer drug shortage

FierceVaccines
FDA approves 6 flu vaccines

PharmAthene's anthrax vax put on hold as shares plummet

Researchers discover malaria target

Immatics' kidney cancer vaccine extends lives in trials

Sanofi readies defense as judge rules antitrust lawsuit can proceed

Health News - BizJournals.com
Income drops, revenue gains, J-Plasma results in at Bovie

Kansas Health Information Exchange to decide whether to grant state control

Dayton's Top 7 Home Health Care Agencies

Aria, Bravo ink health-care contract

Teleflex buying LMA International for $276M

Health News - CNBC
Array BioPharma posts smaller fiscal 4Q loss

Ditching College for Silicon Valley ...

Durata rises; analyst bullish on antibiotic

Having a resident in on surgery is safe: study

Drought-Driven Emerging Market Trades

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
Elan to Cut Loose its Discovery Subsidiary

Some Better News for Avastin

Amgen Anticancer Antibody Bites the Dust

Cushioning the Patent Impact and Preparing for Growth: Analysis of Big Pharma's Diversification Strategies to Overcome Industry Challenges

Alzheimer's Disease Antibody Bombs

Marketwire - Pharma and Biotech
Boston Therapeutics Reports Second Quarter and Six Months 2012 Financial Results

Gemoscan Canada, Inc.: Diet and Wellness Management Now Even Easier With Hemocode(TM) Lite at Rexall(TM) and Rexall Pharma Plus(TM)

ZYTO Reports Record Second Quarter Results

Implanted Electrostimulation Devices Drives $16.3 Billion Market

Acceleware Updates RTM Featuring Enhanced Imaging and NVIDIA Kepler Support

MassBio News
Stericycle Hosting Four FREE DOT Hazmat Trainings for MassBio Members Via Webex

Stericycle Adds SteriSafe for MassBio Members

FierceBiotech will announce 2012 "Fierce 15" at BioPharm America in September

State, Local and Industry Officials Join KeraFAST to Open New Headquarters in Boston, MA

MLSC 2012 Capital Program Announcement

Medical Pharma - PR Newswire
The Heart of Healthcare Websites

New Analysis: Nevada Seniors Face Estimated $20 Million 2013-14 Reduction in Medicare-Funded Nursing Home Care

Hyundai Hope On Wheels Will Kick Off National 5K Run/Walk Series At The University of California, Irvine To Benefit CHOC Children's

UBM Medica US's Physicians Practice Recognized for Editorial Excellence

Minimally Invasive Procedure Offers Patients New Treatment Option For Tendon-Related Injuries

National Center for Biotechnology Information
GenBank Submission Tools Announcements

GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

Nature Biotechnology
Reply to In support of the European Union biosimilar framework

In support of the European Union biosimilar framework

It's the problem, stupid!

Adult stem cell therapies walk the line

Biotech weathers 2Q12 slump

New York Times- Biotechnology
Novel Blood Treatment Lures Athletes in Pain to Germany

Athletes With Chronic Pain Turn to Novel Blood Treatment

Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

Craig Venter’s Bugs Might Save the World

Study Backs Continuous Prostate Cancer Treatment

New York Times- Pharmaceuticals
Pfizer Animal Health Unit Files for I.P.O.

Beware the Nocebo Effect

Amgen, Citing Weak Results, Halts Study of Pancreatic Cancer Drug

Bristol Executive Is Accused of Inside Deals

Prescription Skin Creams Jump in Price

OnBioVC
Stemgent, Inc.: Series C $6.3M

Genalyte, Inc.: Series A $11.8M

Relievant Medsystems, Inc.: Series D $30M

ImaginAb, Inc.: Series A $12.5M

BiO2 Medical, Inc.: Series B $13.7M

Outsourcing-Pharma
Wockhardt targets CMO space for diversification

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

Home visits = regulatory thumbs up ResearchNurses.co thinks so

Home visits are the key to patient retention, says ResearchNurses.co

Kemwell and Boehringer set to finish biologics plant in India

Pharma News - Business Wire
HealthPartners and VitalSims partner to improve diabetes care

Research and Markets: Saudi Arabia's pharmaceutical market will grow at a CAGR of 6.1% to reach $2.43bn in 2017

Research and Markets: The Pharmaceutical Market in the United Arab Emirates: The UAE Pharmaceutical Market to Slow to 16% to 2017

Research and Markets: Clinical Trials In Poland 2012 - 2014

U.S. Neurologists Adoption of STRATIFY JCVTM, the Anti-JC Virus Antibody Assay, Has Shifted Tysabri Earlier in the Treatment of Some Seronegative MS Patients, According to a Recent BioTrends Report

Pharma News - PharmiWeb
Astellas Pharma Europe Ltd. appoints Dr Susan Wood as Senior Director, Market Access

Dr. Fuhrman Crowdfunds Groundbreaking Nutritional Research

Sunrise reader is a real winner for celiac patients

AdamEve.com Quizzes Americans on Favorite Sex Position

New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug

Pharma News - PR Newswire
The Partnership at Drugfree.org, Outside The Wire and Phoenix House Examine Substance Abuse and Creativity Through Innovative Public Health Project

TeleManager Changes Pharmacy-Patient Communication with iRefill Connect Suite

Keeping Bugs at Bay

Physicians Find Medical Billers and Coders Within 48 Hours of Posting Jobs with MBC

Mylan Specialty Offers Free EpiPen® (epinephrine) Auto-Injectors to Schools Nationwide

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Romer Labs Launches New Website

SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

PRWeb - Biotechnology
Wedbush PacGrow Life Sciences Releases Top Sector Trends for...

Michigan Oncology Medical Home Demonstration Project Now Underway

The #1 Technothriller of 2011 (and NY Times Bestseller) Now Only $3.95

V-Rooms Releases White Paper: Accelerating Translational Research and...

Stemedica International Receives Licenses From Swissmedic For Import...

PRWeb - Pharmaceuticals
Benefit Brainstorm Announces the Launch of Freshbenies to...

ComplianceOnline Announces Seminars on Auditing the Human Resource...

Kianomer Dead Sea Announces New Acne Treatment Discount Deals

15ColonCleansers.com Expands Their Reach with SEO Service Group

New Findings Advance Industry Understanding of Standardizing in Vitro...

Scientific American
Common Lab Dye Found to Interrupt Formation of Huntington's Disease Proteins

Prosthetic Retina Helps to Restore Sight in Mice

Exxon Valdez Laid to Rest

Shark-Tooth Weapons Reveal Lost Biodiversity

Invasive Fungi Wreak Havoc on Species Worldwide [Slide Show]

Sports - ESPN Basketball
Lumpkins to return to American's hoops team

Nova coach with resume discrepancies resigns

Nova asst. resigns due to resume inaccuracies

Despite claims, no record of Nova asst. playing

Villanova investigating new assistant's resume

Sports News - ESPN
Sources: 2-horse race to host Champions Bowl

Miles quiet about possible return of Mathieu

Experts: Penn St. warning is serious, necessary

Big East Conference hires Aresco as commish

Ex-Penn St. president's lawyers to rebut report

Xconomy Life Sciences
Remove the Cap on Social Security

Kineta Pulls in $5.8M for Autoimmune Drug

Elcelyx Therapeutics Raises $4M to Treat Obesity and Diabetes

Relypsa Gets Another $50M for Drug to Fight Excess Potassium

Brace Yourself: Biotech IPOs Are Beating Tech's Big Names

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)